Vnitr Lek 2007, 53(1):38-45

The importance of determination of Nt-proBNP and big endothelin in diagnosing chronic heart failure in patients on regular haemodialysis treatment

O. Ludka1,*, J. ©pinar1, L. Vítovcová2, D. Sobotová2, L. ©pinarová3, J. Vítovec3, J. Tomandl4
1 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Jindřich ©pinar, CSc., FESC
2 II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.
3 I. interní kardioangiologická klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC
4 Biochemický ústav Lékařské fakulty MU Brno, přednostka prof. RNDr. Eva Táborská, CSc.

We have followed 99 patients with end stage renal failure, treated by regular haemodialysis. Chronic renal failure is frequently accompanied by chronic heart failure (over 50 %), especially by heart failure with preserved ejection fraction. Patients treated by regular haemodialysis had a tendency to cardiomegaly (51 %), mild systolic dysfunction of the left ventricle (mean LVEF 53 %) and diastolic dysfunction (88 %) of the hypertrophic left ventricle. They had also activated endothelin and neurohumoral system. Only 3 % of the patients had normal values of Nt-proBNP and big endothelin. The plasma level of Nt-proBNP in haemodialysed patients correlated with cardiothoracic ratio and with ejection fraction. The plasma level of big endothelin correlated only with cardiothoracic ratio.

Keywords: congestive heart failure; hemodialysis; neurohumoral activation

Received: July 12, 2006; Accepted: September 14, 2006; Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ludka O, ©pinar J, Vítovcová L, Sobotová D, ©pinarová L, Vítovec J, Tomandl J. The importance of determination of Nt-proBNP and big endothelin in diagnosing chronic heart failure in patients on regular haemodialysis treatment. Vnitr Lek. 2007;53(1):38-45.
Download citation

References

  1. Cataliotti A, Malatino LS, Jougasaki M. Circulating natriuretic peptide concentration in patiens with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001; 76: 1111-1119. Go to original source... Go to PubMed...
  2. Clerico A, Caprioli R, Del Ry S. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patiens with renal failure on chronic hemodialysis. J Endocrinol Invest 2001; 24: 24-30. Go to original source... Go to PubMed...
  3. Fagugli RM, Palubo B, Ricciardi D et al. Association between Brain Natriuretic Peptide and Extracellular Water in Hemodialysis Patiens. Nephron Clin Pract 2003; 95: 60-66. Go to original source... Go to PubMed...
  4. Iwashima Y, Horio T, Takami Y et al. Effects of the Creation of Arteriovenous Fistula for Hemodialysis on Cardiac Function and Natriuretic Peptide Levels in CRF. Am J Kidney Dis 2002; 40: 974-982. Go to original source... Go to PubMed...
  5. Lee SW, Song JH, Kim GA et al. Plasma Brain Natriuretic Peptide Concentration on Assessment of Hydratation status in Hemodialysis Patient. Am J Kidney Dis 2003; 41: 1257-1266. Go to original source... Go to PubMed...
  6. Naganuma T, Sugimura K, Wada S. The prognostic role of brain natriuretic peptides in hemodialysis patiens. Am J Nephrol 2002; 22: 437-444. Go to original source... Go to PubMed...
  7. Nishimura M, Hashimoto T, Kobayashi H et al. Different Remodeling against Left Ventricular Overload between Diabetic and Non Diabetic Haemodialysis Patiens. Clinical and Experimental Pharmacology and Physiology 2003; 30: 786-792. Go to original source... Go to PubMed...
  8. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 2005; 26: 1115-1140. Go to original source... Go to PubMed...
  9. ©pinar J, Hradec J, Málek I et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání. Cor et Vasa 2001; 43: 123-137.
  10. ©pinar J, Vítovec J, ©pác J et al. Non-invasive prognostic factors in chronic heart failure. One year survival of 300 patients with diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy. Int J of Cardiology 1996; 56: 283-288. Go to original source... Go to PubMed...
  11. ©pinar J, ©pinarová L, Vítovec J et al. Big endothelin and chronic heart failure. Vnitř Lék 2002; 48: 3-7.
  12. ©tejfa M et al. Kardiologie. 2. ed (přepracované a doplněné vydání). Praha: Grada Publishing 1998.
  13. Sulková S et al. Hemodialýza. Praha: Maxdorf 2000.
  14. Vesely DL. Natriuretic Peptides and Acute Renal Failure. Am J Physiol Renal Physiol 2003; 285: 167-177. Go to original source... Go to PubMed...
  15. Wahl HG, Graf S, Renz H et al. Elimination of the Cardiac Natriuretic Peptides B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP by Hemodialysis. Clinical Chemistry 2004; 50: 1071-1074. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.